Search

Tom Scalera and Brett Ravage found a second chance at love through the MSK community after losing their spouses to cancer in 2019. Together, they have raised more than $10 million for cancer research.

… Friday, June 6, 2025 It was a magical late autumn evening last year, in the heart of a charming Connecticut town. Family and friends had gathered to celebrate the marriage of Brett Ravage and Tom Scalera, a beautiful couple getting a second chance at love.   But what makes Brett and Tom’s wedding extraordinary

Honors were conferred, PhD degrees were awarded, and a Pulitzer Prize-winning author addressed the graduates at the May 10 ceremony.

… Monday, July 8, 2013 Summary Honors were conferred, PhD degrees were awarded, and a Pulitzer Prize-winning author addressed the graduates at the May 10 ceremony. Pictured: 2013 Graduates The 2013 graduates of the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences Pictured: Siddhartha Mukerjee

Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer.

… Friday, February 28, 2025 Summary U.S. health officials have expanded the recommended age range for people receiving the HPV vaccine to protect against several types of cancer to people in their mid-40s. MSK physicians offers advice for people considering the vaccine in their 20s, 30s, and 40s. The approved

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.

… Saturday, June 2, 2018 Summary Researchers have hoped that drugs blocking a disease pathway called PI3K will slow breast cancer growth. Now a phase III clinical trial testing a drug called taselisib in combination with hormone therapy shows that this strategy can be effective. One of the most inviting

Physicians at Memorial Sloan Kettering Cancer Center (MSK) have developed and validated clinical calculators to help patients estimate their likelihood of avoiding a recurrence after treatment for colorectal cancer.

… Tuesday, November 8, 2022 Physicians at Memorial Sloan Kettering Cancer Center (MSK) have developed and validated clinical calculators to help patients estimate their likelihood of avoiding a recurrence after treatment for colorectal cancer. The newest calculator can help patients decide whether to proceed

Memorial Sloan Kettering Cancer Center (MSK) experts shared the results from cutting-edge advances in cancer research at the European Society of Medical Oncology (ESMO) Congress 2024, held in Barcelona, Spain, September 13 to 17, 2024.

… Tuesday, September 17, 2024 Memorial Sloan Kettering Cancer Center (MSK) experts shared the results from cutting-edge advances in cancer research at the European Society of Medical Oncology (ESMO) Congress 2024, held in Barcelona, Spain, September 13 to 17, 2024. Highlights included promising advances

A large cohort of patients with high-risk bladder cancer who underwent radical cystectomy and urinary tract reconstruction at Memorial Sloan Kettering Cancer Center reported favorable recovery and health-related quality of life within 24 months across most outcome measures.

… Tuesday, June 28, 2022 A large cohort of patients with high-risk bladder cancer who underwent radical cystectomy and urinary tract reconstruction at Memorial Sloan Kettering Cancer Center (MSK) reported favorable recovery and health-related quality of life (HRQOL) within 24 months across most outcome

Read our suggestions for getting through the holiday season while facing cancer.

… Tuesday, November 7, 2017 Summary The holiday season brings unique challenges for people with cancer. Social worker Jackie LaGrassa has tips for how to manage. The holidays are stressful enough. Having cancer can make for an especially trying season. “There are expectations that you’re going to show

Cancer knows no borders or languages. For most people newly diagnosed with cancer, it’s hard enough trying to understand their diagnosis, treatment options, and the life changes that lie ahead without also having to contend with a language barrier. The challenges are even more daunting for people facing an advanced, life-threatening disease.

… Wednesday, April 13, 2022 Cancer knows no borders or languages. For most people newly diagnosed with cancer, it’s hard enough trying to understand their diagnosis, treatment options, and the life changes that lie ahead without also having to contend with a language barrier. The challenges are even more

El cáncer no conoce fronteras ni idiomas. Para la mayoría de las personas recién diagnosticadas con cáncer, ya es bastante difícil tratar de comprender su diagnóstico, las opciones de tratamiento y los cambios de vida que les esperan sin tener que lidiar con una barrera del idioma. Los desafíos son aún más desalentadores para las personas que enfrentan una enfermedad avanzada y potencialmente mortal.

… Wednesday, April 13, 2022 El cáncer no conoce fronteras ni idiomas. Para la mayoría de las personas recién diagnosticadas con cáncer, ya es bastante difícil tratar de comprender su diagnóstico, las opciones de tratamiento y los cambios de vida que les esperan sin tener que lidiar con una barrera del